Corporate Information | Press & Media | For Investors

[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer

by

 Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.

[Press Release] ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative

by

ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.

ThinkGenetic Partners with Genome Medical

by

New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com),  a nationwide specialty medical practice […]

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.